The National Institutes of Health (NIH) will invest more than $190 million over the next five years to accelerate an emerging field of biomedical research known as epigenomics.
“Disease is about more than genetics. It’s about how genes are regulated — how and when they work in both health and disease,” said NIH Director Elias A. Zerhouni, M.D. “Epigenomics will build upon our new knowledge of the human genome and help us better understand the role of the environment in regulating genes that protect our health or make us more susceptible to disease.”
The NIH is making this a priority in its research portfolio, taking it on as an NIH Roadmap initiative. Grant applications are now being accepted for research on epigenome mapping centers, epigenomics data analysis and coordination, technology development in epigenetics, and discovery of novel epigenetic marks in mammalian cells.
Release date: January 22, 2008
Source: National Institutes of Health
Filed Under: Genomics/Proteomics